丹麦队列研究:慢性丙肝及肝硬化患者死亡率对比普通人群
结果显示肝硬化患者调整死亡率比为5.64,无肝硬化者为1.94;肝硬化本身与死亡率比4.03相关。丙肝治愈在肝硬化患者中与死亡率比0.64相关,但该人群死亡率仍高于普通人群。
要点
- 慢性丙肝患者无论是否肝硬化,死亡率均高于普通人群。
- 肝硬化使死亡风险显著增加,调整死亡率比达4.03。
- 肝硬化患者治愈丙肝后死亡风险降低,但仍高于普通人群。
核心结论
- 慢性丙肝伴或不伴肝硬化患者的全因死亡率均高于普通人群。
- 治愈丙肝与肝硬化患者死亡率降低相关,但死亡率仍高于普通人群。
研究设计与样本
- 丹麦全国登记队列研究,纳入丹麦乙肝和丙肝数据库中有肝纤维化评估的慢性丙肝患者。
- 肝纤维化通过肝活检、瞬时弹性成像和临床肝硬化评估。
主要发现
- 肝硬化患者与对照相比调整死亡率比为5.64(95%CI 4.76-6.67)。
- 无肝硬化患者与对照相比调整死亡率比为1.94(95%CI 1.55-2.42)。
- 肝硬化与死亡率比4.03(95%CI 3.43-4.72)相关。
- 肝硬化患者中丙肝治愈与死亡率比0.64(95%CI 0.40-1.01)相关。
- 丙肝治愈者与普通人群相比死亡率比为2.33(95%CI 1.47-3.67)。
临床怎么用
- 临床应关注慢性丙肝患者(尤其肝硬化者)的高死亡风险,积极管理肝硬化并发症。
- 对肝硬化患者应推荐丙肝治愈治疗,以降低死亡风险。
- 治愈后仍需长期监测,因死亡率仍高于普通人群。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Knowledge about mortality rates (MRs) in patients with chronic hepatitis C (CHC) with cirrhosis is limited. This study aimed to estimate all-cause MRs among patients with CHC with or without cirrhosis in Denmark compared with the general population. METHODS: Patients registered in the Danish Database for Hepatitis B and C with CHC and a liver fibrosis assessment were eligible for inclusion. Liver fibrosis was assessed by means of liver biopsy, transient elastography, and clinical cirrhosis. Up to 20 sex- and age-matched individuals per patient were identified in the general population. Data were extracted from nationwide registries. RESULTS: A total of 3410 patients with CHC (1014 with cirrhosis), and 67 315 matched individuals were included. Adjusted MR ratios (MRRs) between patients with or without cirrhosis and their comparison cohorts were 5.64 (95% confidence interval [CI], 4.76-6.67) and 1.94 (1.55-2.42), respectively. Cirrhosis among patients was associated with an MRR of 4.03 (95% CI, 3.43-4.72). A cure for CHC was associated with an MRR of 0.64 (95% CI, 0.40-1.01) among cirrhotic patients and 2.33 (1.47-3.67) compared with the general population. CONCLUSIONS: MRs were high among patients with CHC with or without cirrhosis compared with the general population. Curing CHC was associated with a reduction in MR among cirrhotic patients, but the MR remained higher than the general population.
引用
- Hallager S, Brehm Christensen P, Ladelund S, et al. Mortality Rates in Patients With Chronic Hepatitis C and Cirrhosis Compared With the General Population: A Danish Cohort Study. J Infect Dis. 2017. PMID: 27803168. doi:10.1093/infdis/jiw527
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。